Shortly after the Centers for Disease Control and Prevention (CDC) released guidance on Zika virus infection and pregnancy yesterday, Illinois officials reported two imported cases in pregnant women, a potential risk for birth defects.
The organizations have signed an agreement worth $5 million to advance the VSV-EBOV vaccine.
The infected woman is an aunt of the recently reported Ebola patient whose death marked the end of Ebola-free status in West Africa.
Guangdong province in China has confirmed its fifth H5N6 avian flu infection in 3 weeks, the world's ninth such case, and Fujian province reported its first H7N9 avian flu case of the winter, Xinhua reported today.
Just hours after the WHO declared the end of Ebola virus transmission in the outbreak region, the agency confirms a new, fatal case.
The WHO also warned of the risk of flare-ups due to ligering virus in some survivors, a threat it says will decline with time.
Experts called together in the wake of the Ebola crisis laid out ways to better prepare for the next threat.
According to the first-ever global burden estimates for melioidosis, the disease is sharply underreported in 45 endemic countries, it's probably endemic in 34 more, and conditions are suitable for the disease in parts of the United States and Japan.
Johnson & Johnson's prime-boost Ebola vaccine regimen is entering phase 2 clinical trials in both healthy and HIV-infected people, the Walter Reed Army Institute of Research (WRAIR) announced yesterday in a press release.
Also, a short report notes gender differences during the outbreak, such as higher survival in females.
